Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
17709 | 522 | 40.6 | 83% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DISINTEGRIN | Author keyword | 62 | 44% | 21% | 109 |
2 | DISINTEGRINS | Author keyword | 18 | 45% | 6% | 30 |
3 | ECHISTATIN | Author keyword | 16 | 51% | 4% | 22 |
4 | TRIFLAVIN | Author keyword | 15 | 82% | 2% | 9 |
5 | RECOMBINANT DISINTEGRIN | Author keyword | 11 | 100% | 1% | 6 |
6 | KISTRIN | Author keyword | 9 | 83% | 1% | 5 |
7 | CONTORTROSTATIN | Author keyword | 8 | 100% | 1% | 5 |
8 | CANC 106 | Address | 7 | 67% | 1% | 6 |
9 | FLAVORIDIN | Author keyword | 6 | 80% | 1% | 4 |
10 | SALMOSIN | Author keyword | 6 | 71% | 1% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DISINTEGRIN | 62 | 44% | 21% | 109 | Search DISINTEGRIN | Search DISINTEGRIN |
2 | DISINTEGRINS | 18 | 45% | 6% | 30 | Search DISINTEGRINS | Search DISINTEGRINS |
3 | ECHISTATIN | 16 | 51% | 4% | 22 | Search ECHISTATIN | Search ECHISTATIN |
4 | TRIFLAVIN | 15 | 82% | 2% | 9 | Search TRIFLAVIN | Search TRIFLAVIN |
5 | RECOMBINANT DISINTEGRIN | 11 | 100% | 1% | 6 | Search RECOMBINANT+DISINTEGRIN | Search RECOMBINANT+DISINTEGRIN |
6 | KISTRIN | 9 | 83% | 1% | 5 | Search KISTRIN | Search KISTRIN |
7 | CONTORTROSTATIN | 8 | 100% | 1% | 5 | Search CONTORTROSTATIN | Search CONTORTROSTATIN |
8 | FLAVORIDIN | 6 | 80% | 1% | 4 | Search FLAVORIDIN | Search FLAVORIDIN |
9 | SALMOSIN | 6 | 71% | 1% | 5 | Search SALMOSIN | Search SALMOSIN |
10 | RGD CONTAINING PEPTIDE | 5 | 63% | 1% | 5 | Search RGD+CONTAINING+PEPTIDE | Search RGD+CONTAINING+PEPTIDE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VIPER VENOMS | 72 | 61% | 14% | 75 |
2 | ERISTOCOPHIS MACMAHONI VENOM | 48 | 100% | 3% | 17 |
3 | HETERODIMERIC DISINTEGRIN | 46 | 74% | 7% | 34 |
4 | PLATELET AGGREGATION INHIBITOR | 34 | 34% | 16% | 81 |
5 | DISULFIDE BOND PATTERN | 26 | 80% | 3% | 16 |
6 | SNAKE VENOM DISINTEGRIN | 25 | 58% | 6% | 29 |
7 | ANTIPLATELET PEPTIDE | 24 | 82% | 3% | 14 |
8 | FLAVOVIRIDIS SNAKE VENOM | 23 | 79% | 3% | 15 |
9 | DIMERIC DISINTEGRIN | 23 | 86% | 2% | 12 |
10 | SNAKE VENOM DISINTEGRINS | 22 | 68% | 4% | 19 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The continuing saga of snake venom disintegrins | 2013 | 16 | 58 | 66% |
From snake venom toxins to therapeutics - Cardiovascular examples | 2012 | 32 | 115 | 26% |
Non-RGD-containing snake venom disintegrins, functional and structural relations | 2011 | 12 | 52 | 48% |
Disintegrins in health and disease | 2008 | 25 | 111 | 68% |
Viper venom disintegrins and related molecules | 1998 | 130 | 94 | 50% |
Structure-function correlations of snake venom disintegrins | 2005 | 33 | 53 | 64% |
Applications of snake venom components to modulate integrin activities in cell-matrix interactions | 2013 | 4 | 120 | 55% |
Anti-angiogenesis and-RGD-containing snake venom disintegrins | 2007 | 33 | 100 | 29% |
Functional characteristic of snake venom disintegrins: Potential therapeutic implication | 2005 | 57 | 144 | 35% |
DISINTEGRINS - A FAMILY OF INTEGRIN INHIBITORY PROTEINS FROM VIPER VENOMS | 1990 | 370 | 26 | 58% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CANC 106 | 7 | 67% | 1.1% | 6 |
2 | NAT TOXINS | 5 | 32% | 2.7% | 14 |
3 | CANC S 106 | 3 | 100% | 0.6% | 3 |
4 | SERV CENT SOPORTE INVEST EXPT | 1 | 38% | 0.6% | 3 |
5 | CNRS ESA 5075 | 1 | 50% | 0.4% | 2 |
6 | CNRS UMR 5538 | 1 | 100% | 0.4% | 2 |
7 | ETUDE ADHES CELLULAIRE | 1 | 100% | 0.4% | 2 |
8 | MCKINLY 057 | 1 | 100% | 0.4% | 2 |
9 | PROT ENGN 460 POINT SAN BRUNO BLVD | 1 | 100% | 0.4% | 2 |
10 | BIOL CELLULAIRE HYPERTENS | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000269791 | C TYPE LECTIN LIKE PROTEIN//ANTICOAGULATION FACTOR I//ANTICOAGULATION FACTOR II |
2 | 0.0000169465 | ALPHAVBETA3 INTEGRIN//CILENGITIDE//ALPHAVBETA3 |
3 | 0.0000146372 | GLANZMANN THROMBASTHENIA//GLANZMANNS THROMBASTHENIA//THROMBASTHENIA |
4 | 0.0000141334 | SNAKE BITE//ANTIVENOM//TOXICON |
5 | 0.0000104933 | EPTIFIBATIDE//TIROFIBAN//ABCIXIMAB |
6 | 0.0000085118 | ALPHA 6 BETA 4 INTEGRIN//INTEGRIN ALPHA 6 BETA 4//CANC BIOL ANGIOGENESIS |
7 | 0.0000076092 | NEPHRONECTIN//VLA 1//ALPHA 8 INTEGRIN |
8 | 0.0000074163 | ADAM//ADAM8//ADAM17 |
9 | 0.0000068134 | BRADYKININ POTENTIATING PEPTIDE//RONDON COMMISSION//CARLOS CHAGAS |
10 | 0.0000062955 | THROMBOCYTOSIS//TCIPA//TUMOR CELL INDUCED PLATELET AGGREGATION |